Volume 12, Issue 6 (8-2014)                   IJRM 2014, 12(6): 409-0 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Shen C, Shu D, Zhao X, Gao Y. Comparison of clinical outcomes between fresh embryo transfers and frozen-thawed embryo transfers. IJRM 2014; 12 (6) :409-0
URL: http://ijrm.ir/article-1-552-en.html
1- Department of Obstetrics and Gynecology, :union: Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan Hubei 430022,
2- Department of Obstetrics and Gynecology, :union: Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan Hubei 430022, China
3- Department of Obstetrics and Gynecology, :union: Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan Hubei 430022, China , gying13@163.com
Full-Text [PDF 226 kb]   (740 Downloads)     |   Abstract (HTML)  (2871 Views)
Full-Text:   (396 Views)
Introduction
 
The first cleavage-stage embryo was transferred by Edwards in 1978. After five years, Trounson transferred the first frozen-thawed embryo and the patient get pregnant (1). With the development of assisted reproductive technology (ART), fresh blastocysts transfer, frozen-thawed cleavage-stage embryo transfer, and frozen-thawed blastocyst transfer had good pregnancy outcomes. However, how to promote pregnancy rate is the focus of attention. Embryo and endometrial receptivity are the important factors. Blastocyst culture can select available embryo through extended culture, on the other hands, the better synchronization of embryo-endometrium improve endometrial receptivity (2).
Recently, many researches showed frozen-thawed embryo transfers can enhanced the embryo utilization rate and improve the success rate (3, 4). Estrogen-progesterone (E-P) cycles or nature cycles were adopted in frozen-thawed embryo transfer (3). This study was aimed to compare the fresh embryo transfer with frozen-thawed embryo transfer to evaluate an optimal embryo transfer protocol.
 
Materials and methods
 
The study performed from Jan 2012 to Dec 2012 in Assisted Reproduction of Wuhan ::union:: Hospital. A total of 1891 cycle contains 1150 fresh embryo transfers and 741 frozen-thawed embryo transfers. The 1150 women were composed with cleavage-stage (n=799 <35 years old and n=194 ≥35 years old, respectively) or blastocyst-stage (n=131, <35 years old and n=26, ≥35 years old, respectively). 741 women also were divided into cleavage-stage (n=159, <35 years old and n=53, ≥35 years old, respectively) or cleavage-stage extended blastocyst culture (n=111, <35 years old and n=26, ≥35 years old respectively) or blastocyst-stage transfer (n=276, <35 years old and n=52, ≥35 years old, respectively).
 
Process of IVF
A long gonadotropin releasing hormone (GnRH) agonist protocol was used in all cycles. When two or more follicles reached 18 mm in diameter, 10000 units of HCG was injected and then ovum pick up (OPU) was performed 34-36 hours later. In vitro fertilization (IVF) or Intracytoplasmic sperm injection (ICSI) was performed 4 to 6 hours after OPU. Embryo assessment was based on morphology and rate of development. The grade of D3 embryos were scored on a scale of 1-4, where 1 and 2 were good embryo, 3-4 were bad embryo. Then we performed D3 embryo transfer or transferred them to blastocyst medium, culturing for further 2-3 days to form blastocyst. Blastocysts were scored according to Gardner standard (5).
We usually transferred 1 or 2 good embryos. All surplus good quality embryos were cryopreserved through vitrification. The E-P cycle or nature cycle was administrated according to the characteristics of patients. The double thickness of the endometrium which exceeded 8 mm was available. Clinical pregnancy was defined by the observation of a gestational sac with or without a fetal heartbeat on ultrasound evaluation on the 30th day after embryo transfer. The number of sacs was taken as the number of implantations.
 
Statistical analysis
All statistical calculations were done by SPSS software. Logistic regression analysis was used to adjust the confounding factors to compare the embryo clinical pregnancy rates between the two groups. P<0.05 was considered statistically significant.
 
Results
 
For patients under 35 years old, a total of 930 fresh embryo transfers were assigned to fresh cleavage-stage embryo (n=799) and fresh blastocyst transfers (n=131). There are significant differences in some clinical characteristics (age, the number of oocyte and the number of transferring good-quality embryo) between two groups (Table I). The clinical pregnancy rates in the fresh cleavage-stage embryo and fresh blastocyst transfers were 52.7% and 35.88% (p<0.0001). But the multiple pregnancy rates had no statistically significant difference between the two groups (34.92% vs. 29.79%), also the same were the abortion rates and ectopic pregnancy rates (5.7% vs. 4.25%, and 3.32% vs. 0%). For patients older than 35 years old, fresh cleavage-stage embryo (n=194) and fresh blastocyst transfer (n=26) have no difference in clinical characteristics (Table II). There are significantly different in clinical pregnancy rates between two groups (41.24% vs. 26.92%). There were no significant differences between the two groups with respect to multiple pregnancy rates, abortion rates and ectopic pregnancy rates.
A total of 741 frozen-thawed embryo transfers were assigned to frozen-thawed cleavage-stage embryo transfers (n=159, <35 years and n=53, ≥35 years), post-thaw extended culture blastocyst transfers (n=111, <35 years and n=26, ≥35 years) and frozen-thawed blastocyst transfers (n=276, <35 years and n=52, ≥35 years) (Table III and IV). The clinical pregnancy rates of the frozen-thawed cleavage-stage embryo transfers and frozen-thawed blastocyst transfers were 35.29% and 59.8% (<35 years old), and 11.32% and 55.8% (≥35 years old) (p<0.0001). Frozen-thawed blastocyst transfers versus post thaw extended culture blastocyst transfers were 47.75% vs. 59.8% (<35 years old), and 46.15% vs. 55.8% (≥35years old) (p<0.0001).
The multiple pregnancy rates after frozen-thawed cleavage-stage embryo transfers, post-thaw extended culture blastocyst transfers and frozen-thawed blastocyst transfer were 31.48%, 33.96% and 31.52% (<35 years), and 16.67%, 25% and 17.24% (≥35 years). Abortion rates after frozen-thawed cleavage-stage embryo transfers, post-thaw extended culture blastocyst transfers and frozen-thawed blastocyst transfers were 9.26%, 13.21% and 10.9% (<35 years), and 33.33%, 16.67% and 17.24% (≥35 years).
Ectopic pregnancy rates after frozen-thawed cleavage-stage embryo transfers, post-thaw extended culture blastocyst transfers and frozen-thawed blastocyst transfers were 0, 3.78% and 1.82% (<35 years), and 0%, 0% and 3.45% (≥35 years). There were no significantly different among three group with respect to clinical outcomes except for clinical pregnancy rate whatever the patients under 35 years or older than 35 years.
There were no differences between the fresh cleavage-stage embryo transfers and frozen-thawed cleavage-stage embryo transfers in the clinical characteristics of age, and dosage of gonadotropin were different in ≥35 years (Table V). The clinical pregnancy rates differ significantly between the fresh cleavage-stage embryo transfers and frozen-thawed cleavage-stage embryo transfers  (52.7% vs. 35.29%, <35 years and 41.24% vs. 11.32%, ≥35 years). The multiple pregnancy rates of the fresh cleavage-stage embryo transfers and frozen-thawed cleavage-stage embryo transfers were 34.92% vs. 31.48% (<35 years) and 22.5% vs. 16.67% (≥35 years), while the abortion rates were 5.7% vs. 9.26% (<35 years) and 8.75% vs. 33.33% (≥35 years), the ectopic pregnancy rates were 3.32% vs. 0% (<35 years) and 0% vs. 0% (≥35 years). There were no different between the groups.
For patients under 35 years of age, the numbers of good embryo transferred were different in the fresh cleavage-stage embryo transfers and frozen-thawed blastocyst transfers. The clinical pregnancy rates after the fresh cleavage-stage embryo transfers and frozen-thawed blastocyst transfers were different (52.7% vs. 59.8%). But other clinical outcomes, for example multiple pregnancy rates, abortion rates, and ectopic pregnancy rates had no difference. For patients older than 35 years old, the clinical characteristics, for example, dose of gonadotropin, retrieved of oocyte, and number of good embryo transferred were different significantly between the fresh cleavage-stage embryo transfers and frozen-thawed blastocyst transfers (41.24% vs. 55.8%). Whereas the multiple pregnancy rates, abortion rates, and ectopic pregnancy rates had no difference (Table VI).




Table I. comparison with fresh cleavage-stage embryo transfer and fresh blastocyst transfer (age <35 years)





Table II. Comparison with fresh cleavage-stage embryo transfer and fresh blastocyst transfer (age ≥35 years)




Table III. Comparison with three types of frozen-thawed embryo transfers (age <35 years)



Table IV. Comparison with three types of frozen-thawed embryo transfers (age >35 years)



Table V. Comparison with fresh cleavage-stage embryo transfers and frozen-thawed cleavage-stage embryo transfers



Table VI. Comparison with fresh cleavage-stage embryo transfers and frozen-thawed blastocyst transfers


Discussion
 
The study showed a higher clinical pregnancy rate in fresh cleavage-stage embryo transfers than frozen-thawed cleavage-stage transfers. But some researches claimed fresh embryo transfers had a lower clinical pregnancy rate than frozen-thawed embryo transfers (3, 6). There was a difference that the embryos were included cleavage-stage and blastocyst. Our research also showed the clinical pregnancy rates were significantly highest in the frozen-thawed blastocyst transfer among fresh embryo transfers and frozen-thawed embryo transfers. We inferred that the ability of development in frozen-thawed cleavage-stage embryos may be lower than the fresh cleavage-stage embryos.
The influence of blastocyst after cryopreservation may be little. The cleavage-stage embryos did not induce self-selection through the extended culture. So the ability of resistance may be weaker than blastocyst. The result was in according with many studies (3, 7, 8). One study indicated that high serum oestradiol concentrations may adversely affect endometrial receptivity, but the embryo quality was not affected (9). Morphology study of Basir et al revealed that high oestradiol concentrations in COH cycles induced delayed glandular maturation and advanced stromal morphology, whereas moderate oestradiol concentrations showed synchronous development of grandular and stromal features. Endometrial characteristic of pre-ovulation were different between the COH cycles and natural cycles (10, 11). Gene study of Horcajadas et al demonstrated more than 200 genes had abnormal expression during the window of implantation when COH cycle compared with normal cycles. Gene expression profiles of the endometrium during COH produced a suboptimal endometrial development (12).
Liu et al found there were lots of abnormal morphology oocytes and delayed development and maturation in high dose of oestradiol. Finally the oocytes would be differently fertilized by sperms (13). The oestradiol concentrations in COH cycles were inevitably higher than this in the nature cycles. We also found the clinical pregnancy rates of fresh blastocyst transfers were lower than fresh cleavage-stage embryo transfers. Some studies showed the opposite outcomes (14). But some other reports support us (8, 15). In our centre, we usually transfer fresh cleavage-stage embryo in fresh cycles. Yet when the patients have some clinical symptoms, for example OHSS, pelvic effusion, endometrial cavity fluid, thick endometrium, a failure or more after IVF-ET, we cultured the embryos 2-3 days until blastocyst formed, then transferred the blastocyst if the patients were in good condition. This condition may influence pregnancy outcomes.
Recently, studies indicated there were high ectopic pregnancy rates in fresh embryo transfer cycles. The reason may be the high gonadotropin in ovarian stimulation cycles (16). The statistics in our study showed no difference in the ectopic pregnancy between fresh embryo transfers and frozen-thawed embryo transfers. Maybe, fresh and frozen-thawed embryo transfers were divided into cleavage-stage and blastocyst to analyze. The abortion rate in frozen-thawed embryo transfer was higher than fresh embryo transfer. Some reports supported the view (17, 18).
Cleavage-stage embryo and blastocyst may inevitably be damaged during cryopreservation. This may damage the ability of development, thus result in abortion (18). Aytoz et al indicated the cryopreservation process had no negative impact on the outcome of pregnancy over 20 weeks of gestation (17). There were no differences in low-birthweight, birth defects and perinatal death between the fresh embryo transfers and frozen-thawed embryo transfers (19).
 
Conclusion
 
In conclusion, the optimal embryo transfer protocol is fresh cleavage-stage embryo transfer if the patients are in good conditions. However, if the patients have some complications such as high oestradiol concentrations on, OHSS, the optimal embryo transfer protocol is culture cleavage-stage embryo to blastocyst and cryopreservation. The clinical pregnancy rates in frozen-thawed blastocyst transfers were high.
 
Acknowledgments
 
We are grateful to the members of Department of Epidemiology and Biostatistics, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology who help to the statistical analysis. We have no specific funding for the study. But the Department of Obstetrics and Gynecology, ::union:: Hospital, Tongji Medical College, Huazhong University of Science and Technology supported us throughout the study period and manuscript preparation.
 
Conflict of interest
 
We declared that we have no conflict of interests of each author.

 
Type of Study: Original Article |

References
1. Trounson A, Mohr L. Human pregnancy following cryopreservation, thawing and transfer of an eight-cell embryo. Nature 1983; 305: 707-709. [DOI:10.1038/305707a0]
2. Papanikolaou EG, Kolibianakis EM, Tournaye H, Venetis CA, Fatemi H, Tarlatzis B, et al. Live birth rates after transfer of equal number of blastocysts or cleavage-stage embryos in IVF. A systematic review and meta-analysis. Hum Reprod 2008; 23: 91-99. [DOI:10.1093/humrep/dem339]
3. Aflatoonian A, Oskouian H, Ahmadi S, Oskouian L. Can fresh embryo transfers be replaced by cryopreserved-thawed embryo transfers in assisted reproductive cycles? A randomized controlled trial. J Assist Reprod Genet 2010; 27: 357-363. [DOI:10.1007/s10815-010-9412-9]
4. Zhou F, Lin XN, Tong XM, Li C, Liu L, Jin XY, et al. A frozen-thawed embryo transfer program improves the embryo utilization rate. Chinese Med J 2009; 122: 1974-1978.
5. Gardner DK, Lane M, Stevens J, Schlenker T, Schoolcraft WB. Blastocyst score affects implantation and pregnancy outcome: towards a single blastocyst transfer. Fertil Steril 2000; 73: 1155-1158. [DOI:10.1016/S0015-0282(00)00518-5]
6. Roque M, Lattes K, Serra S, Sola I, Geber S, Carreras R, et al. Fresh embryo transfer versus frozen embryo transfer in in vitro fertilization cycles: a systematic review and meta-analysis. Fertil Steril 2013; 99: 156-162. [DOI:10.1016/j.fertnstert.2012.09.003]
7. Mesut N, Ciray HN, Mesut A, Aksoy T, Bahceci M. Cryopreservation of blastocysts is the most feasible strategy in good responder patients. Fertil Steril 2011; 96: 1121-1125. [DOI:10.1016/j.fertnstert.2011.08.012]
8. Glujovsky D, Blake D, Farquhar C, Bardach A. Cleavage stage versus blastocyst stage embryo transfer in assisted reproductive technology. Cochrane Database Syst Rev (Online) 2012; 7: CD002118. [DOI:10.1002/14651858.CD002118.pub4]
9. Yu Ng EH, Yeung WS, Yee Lan Lau E, So WW, Ho PC. High serum oestradiol concentrations in fresh IVF cycles do not impair implantation and pregnancy rates in subsequent frozen-thawed embryo transfer cycles. Hum Reprod 2000; 15: 250-255. [DOI:10.1093/humrep/15.2.250]
10. Basir GS, O WS, Ng EH, Ho PC. Morphometric analysis of peri-implantation endometrium in patients having excessively high oestradiol concentrations after ovarian stimulation. Hum Reprod 2001; 16: 435-440. [DOI:10.1093/humrep/16.3.435]
11. Devroey P, Bourgain C, Macklon NS, Fauser BC. Reproductive biology and IVF: ovarian stimulation and endometrial receptivity. Trends Endocrinol Metabol 2004; 15: 84-90. [DOI:10.1016/j.tem.2004.01.009]
12. Horcajadas JA, Riesewijk A, Polman J, van Os R, Pellicer A, Mosselman S, et al. Effect of controlled ovarian hyperstimulation in IVF on endometrial gene expression profiles. Mol Hum Reprod 2005; 11: 195-205. [DOI:10.1093/molehr/gah150]
13. Liu HJ, Chunhui ZhG, Zubing Sh. Impact of total gonadotropin dose on oocyte morphology and clinical outcome in ovarian stimulation cycles. Prog Obstet Gynecol 2006; 15: 295-298.
14. Mangalraj AM, Muthukumar K, Aleyamma T, Kamath MS, George K. Blastocyst stage transfer vs cleavage stage embryo transfer. J Hum Reprod Sci 2009; 2: 23-26. [DOI:10.4103/0974-1208.51339]
15. Tong GQ, Cao SR, Wu X, Zhang JQ, Cui J, Heng BC, et al. Clinical outcome of fresh and vitrified-warmed blastocyst and cleavage-stage embryo transfers in ethnic Chinese ART patients. J Ovarian Res 2012; 5: 27. [DOI:10.1186/1757-2215-5-27]
16. Shapiro BS, Daneshmand ST, De Leon L, Garner FC, Aguirre M, Hudson C. Frozen-thawed embryo transfer is associated with a significantly reduced incidence of ectopic pregnancy. Fertil Steril 2012; 98: 1490-1494. [DOI:10.1016/j.fertnstert.2012.07.1136]
17. Aytoz A, Van den Abbeel E, Bonduelle M, Camus M, Joris H, Van Steirteghem A, et al. Obstetric outcome of pregnancies after the transfer of cryopreserved and fresh embryos obtained by conventional in-vitro fertilization and intracytoplasmic sperm injection. Hum Reprod 1999; 14: 2619-2624. [DOI:10.1093/humrep/14.10.2619]
18. Aflatoonian A, Mansoori Moghaddam F, Mashayekhy M, Mohamadian F. Comparison of early pregnancy and neonatal outcomes after frozen and fresh embryo transfer in ART cycles. J Assist Reprod Genet 2010; 27: 695-700. [DOI:10.1007/s10815-010-9470-z]
19. Shih W, Rushford DD, Bourne H, Garrett C, McBain JC, Healy DL, et al. Factors affecting low birthweight after assisted reproduction technology: difference between transfer of fresh and cryopreserved embryos suggests an adverse effect of oocyte collection. Hum Reprod 2008; 23: 1644-1653. [DOI:10.1093/humrep/den150]

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Designed & Developed by : Yektaweb